后房造漏术联合丝裂霉素C应用治疗晚期新生血管性青光眼疗效观察

The application of the sclerostomy in pesterior chamber combined mitomycin C on late neovascular glaucoma

目的探讨后房造漏术联合丝裂霉素C应用治疗晚期新生血管性青光眼的临床疗效。方法采用巩膜瓣下后房造漏术联合术中使用丝裂霉素C治疗晚期新生血管性青光眼15例(15只眼),术后对眼压、视力、前房、滤过泡形态进行随诊观察分析。结果15例(15只眼)术后经3～24个月观察随访,术前平均眼压(49.23±10.5)mmHg,术后平均(15.6±7.3)mmHg,手术前后有显著性差异(P<0.05);术后视力提高5只眼,不变7只眼;功能性滤过泡占80.00%。结论该术式在眼压控制、滤过泡形成等方面临床效果好,为安全有效的手术方法。

Objective To determine the resets of the Sclerestomy in posterior chamber combined mitomycin C on late neovascular glaucoma. Method 15 cases （ 15eyes ） of late neovascular glaucoma were treated with the methed of sclerostomy in posterior chamher combined mitomycin C . Observe anterior chamber, intrancular pressure, vision, and filtration bleb shape after the therapy,summarize and analyze the curative effect. Results 15 cases 15 eyes were followed up period of 3 - 24 months , the average intraocular pressure （ Iop） before the surgical therapy was 49.23 ± 10.5mmHg, it reduced to 15.6 ±7.3mmHg. After the surgical therapy, there was great difference between before and after the surgical therapy （ P 〈 0.05 ）. Vision no changed after the surgical therapy was 7 eyes,vision risen was 5 eyes. The effective conjunctival follicles was 80%. Conclusion The treatment was good in the aspects of intraocular pressure ,conjunctival follicles. The treatment was safe and effective.